University of Kentucky

Chairman and Chief Executive Officer at Star Brands LLC

Private company specializing in identifying and building value enhanced companies in the companion animal health internet sales and marketing sector.

•	Provide vision, strategic direction, and leadership for businesses seeking to build in the US or globally in the animal health, specialty chemical or agricultural/chemical industries. 

•	Specialize in building through organic growth or acquisitions and selling companies, both through partnerships with private equity or other sources of financing.

Star Brands LLC

Chairman and Chief Executive Officer

Build a “doctor-centric” system of veterinary care for smaller markets and smaller practices that bridges the gap of general and specialty care practices. VetMed elevates and revolutionizes the quality veterinary client experience to build a bond of compassion and trust. Based on synergies, negotiated 10-17% savings on medical equipment and product through a partnership with MWI Animal Health. Assembled a top-level team and secured funding for growth of VetMed Alliance to up to 30 practices within year one.

VetMed Alliance

Founder, Board Member

Acquire and manage firms in the animal healthcare industry. Stratford was acquired in 2018 as part of the efforts to build a global animal healthcare portfolio. Eli Global was in the process of acquiring two additional firms to merge with Stratford, however the deals were put on hold due to the indictment of Eli Global’s founder on federal charges. Under new management, Eli Global sought to divest Stratford Pharmaceuticals. Appointed Chairman of Stratford to grow the business, while negotiating a sale to Swedencare that doubled the Eli investment in under 2 years.

Eli Global; Stratford Pharmaceutical

Chairman

$800M private company engaged in the global distribution of animal health and veterinary products.

•	Started company with financing from private equity firm and accelerated its growth via acquisitions. 

•	Hand selected small focused management group and directed necessary activities for acquiring, turning around, and integrating businesses. 

•	Established efficient platform company poised for global growth by organizing the core business, merging, leveraging and consolidating combined synergies/resources, and putting in place a skilled management team and proven business practices. 

•	Purchased, turned around, and led total transformation of Ivesco, a provider of animal health solutions.

•	Furthered company’s globalization strategy and expanded veterinary product line by acquiring and integrating Centaur Services, $250M company that operates a fully automated veterinary supply facility in the UK and connects veterinarians with the widest range of medicines and veterinary products available.

AHN International LLC

$500M global designer and producer of adhesives and sealants.

•	Purchased ADCO Products as platform company for ADCO Global and subsequently purchased four more global companies.

•	Revitalized the business and created strong platform for global growth by bringing in new senior management, production management, and sales teams. Organized North America/European operations as the global platform. Identified correct market segments to maximize growth. 

•	Improved labor productivity and quality while reducing manufacturing costs by implementing Lean and Six Sigma philosophies. 

•	Executed the acquisition and integration of 5 companies in the construction, industrial, and transportation markets. Divested 2 non-strategic assets. 

•	Expanded global geographic footprint and initiated direct sales presence in China, Italy, and Russia. 

•	Created the world’s largest insulated glass sealant business upon successful acquisitions of Kommerling and Chemetal. 

•	Launched new products (e.g., white roofing, M.S. polymer adhesive and special coil coatings) that drove corporate success while enhancing existing product line by improving formulations.

ADCO Global Inc.

$375M leading global developer, producer and marketer of a wide variety of value-added specialty chemical products sold to a diverse base of over 4000 customers in 50+ countries worldwide. 

•	Recruited by private equity firm to evaluate company that was in Chapter 11 for potential turnaround or sale of assets. Spearheaded strategic business plan centered on improving marketing functions, accelerating product distribution, creating higher-margin, value-added products, strengthening manufacturing operations, expanding company’s capabilities, and identifying potential acquisition targets in the consolidating specialty chemicals industry. 

•	Within 12 months, brought Petrowax out of Chapter 11 and merged with Associated British Industries to create platform company, Astor Corporation. 

•	Successfully transformed commodity business into a leading global specialty chemical product business. 

•	Doubled revenues to $310M+ and tripled EBITDA via internal growth and acquisitions.

•	Accelerated company’s growth and strengthened its product line by acquiring and integrating 6 companies. 

•	Sold company to Allied Signal just prior to IPO at 118% annual return.

Astor Corporation

World’s largest branded animal health and nutrition company with 3400 employees and $650M in sales. Company experienced tremendous growth via purchasing animal health and nutrition assets of Glaxo, Johnson & Johnson, ICI and Burroughs Welcome, and is one of 3 major businesses of IMCERA Group, Inc. 

•	Set global direction for a large, fast-growing company in a fiercely competitive market with emphasis on strategically guiding it to world leadership as a freestanding company of IMCERA Group, Inc., and maximizing earnings and ROIC. Built and guided a global management team in 30 countries. 

•	Instrumental in Pitman-Moore’s transformation from 4 small companies with $140M in sales into a $675M industry leader with an improvement in operational earnings from breakeven to $70M over an 8-year period. 

•	Achieved major strategic impact while establishing R&D as a truly customer-driven function by redirecting $45M R&D effort to selected areas. 

•	Successfully protected earnings by spearheading restructuring and downsizing to address a global price war without disrupting strategic goals.

Pitman-Moore

President / Chief Executive Officer / Chairman

•	Continued to transform company into a dynamic global organization while holding accountability for operational earnings, ROIC, and cash management. 

•	Delivered 80% increase in operational earnings by skillfully integrating acquisitions (including $220M acquisition) and driving internal product growth. 

•	Significantly improved corporate synergies via cost control and headcount reduction while maintaining intense focus on current business and steering strategic direction. 

•	Transformed senior management team to the strongest in the industry by replacing 75% of the team via new hires and changes in key positions with high-caliber individuals. 

•	Expanded company into USSR, China, Japan, and mid-Europe through successful efforts in driving profitability.

Executive Vice President / Chief Operations Officer 

•	Planned, executed, and managed sales and marketing initiatives with scope of responsibility expanding to include finance and R&D functions. 

•	Established a strong sales and marketing operation upon conducting comprehensive analysis of the business, developing new organization structure, and executing personnel changes. 

•	Drove operational earnings from breakeven to $80M+ profit position. 

•	Acquired new products and technologies by developing third party relationship with DuPont, American Cyanamid, ICI, and Upjohn. 

•	Successfully integrated $30M animal health business Glaxo into new organization structure.

Senior Vice President, Sales and Marketing

$380M, 1000-employee manufacturer and distributor of agricultural products, industrial products, and consumer products that was acquired in 1984 by Cheseborough-Ponds. 
 
•	Directed sales and marketing initiatives that were instrumental in turning around a business with sales decline of $400M to $280M returning sales to $480M and company recognition as a market leader. 

•	Replaced 10 out of 11 direct reports with more qualified people to operate the business, established product management system focused on individual products to maximize earnings, redirected R&D to a more customer-focused approach, and created high-impact product advertising and promotional campaigns. 

•	Doubled operational earnings from $20M to $40M in 18 months. Company traded at $41 and was sold to Unilever at $70 per share. 


Previous Experience: Global Director of Marketing, Agricultural Chemical & Commodity Products Division – UNIROYAL, Middlebury, CT; Group Director, Agricultural Chemical & Commodity Products Division – CIBA GEIGY, Greensboro, NC.

Boyd Wainscott